Pharmaceutical & Medical Device Manufacturing Facility

Product Portfolio – Crown Manufacturing Facility

The facility will manufacture a comprehensive range of high-demand pharmaceutical and medical products, designed to meet the healthcare needs of Kenya and the wider region:

Sterile Injectables & Infusion Systems:

• Liquid Injectables

• 100ml & 500ml Eurocap (Medi-Port)

Pharmaceutical Formulations:

• Tablets

• Capsules

• Syrups

Injection & Delivery Systems:

• Conventional and Auto-Disable Syringes

• Hypodermic Needles (Fino-Ject)

Renal Care (NephroSolv Range):

• Acid Concentrates

• Bicarts

• Bloodlines

Hospital & Specialty Consumables:

• Specialty Hospital Consumables

• Rapid Diagnostic Tests

Medical Non-Woven Products:

• Face Masks (MediMask)

• Paper Disposable Envelopes (MediPack)

World-Class Facility Standards & Infrastructure

Covering 240,000 square feet, the facility is designed and built to meet the highest international standards, including:

• GMP (Good Manufacturing Practices)

• WHO-Geneva compliance

• PIC/S certification

To support world-class supply chain efficiency, the plant is fully integrated with a GDP-compliant Automated Storage & Retrieval System (ASRS) — enabling intelligent, secure, and traceable material handling from production to dispatch.

Integrated Pharmaceutical Warehouse – A Strategic Extension

Adjacent to the manufacturing plant, Crown is also developing a next-generation pharmaceutical warehouse, scheduled for completion in December 2025. This facility enhances distribution efficiency and resilience, featuring:

• Fully Automated ASRS (4-Way Shuttle System)

• Robotic Handling Systems

• Temperature- and Humidity-Controlled Storage, including cold chain

• 24/7 Surveillance & Secure Access Control

• SAP-integrated Warehouse Management System (WMS)

• Zebra Barcoding Technology

With 5,000 Euro pallet positions, the warehouse supports both in-house needs and offers Third-Party Logistics (3PL) capabilities for select partners in the pharmaceutical and healthcare sectors.

National & Regional Impact

This dual investment — in both manufacturing and logistics — delivers far-reaching benefits:

• Foreign Exchange Savings
  Local production of essential medicines and devices will reduce import dependency, saving millions annually in foreign currency.

• Employment & Skill Development
  The facility will employ over 800 skilled professionals, contributing to Kenya’s industrial growth and talent advancement.

• Healthcare Sovereignty & Security
  Post-COVID, this investment ensures critical healthcare products are produced locally, bolstering national readiness and self-sufficiency.

• Improved Access & Affordability
  By reducing supply chain costs and production lead times, the plant will enhance availability and lower prices of life-saving treatments.

• Sustainability & Scalability
  Built for the future, the integrated site combines compliance, automation, and operational excellence — setting new industry benchmarks in Africa.

A Vision for Africa’s Healthcare Independence

Crown Healthcare’s commitment goes beyond business — it’s about building Africa’s capability to care for its own. This project signals a future where Kenya stands as a manufacturing, logistics, and innovation powerhouse in the healthcare space.